Dexrazoxane mitigates long-term cardiotoxicities of doxorubicin for young patients
In an interview with Healio, Erin Mobley, Ph.D., discussed her study on the cardioprotective effects of dexrazoxane in pediatric cancer survivors.
In an interview with Healio, Erin Mobley, Ph.D., discussed her study on the cardioprotective effects of dexrazoxane in pediatric cancer survivors.
Researchers combed through data about whether outdated cancer screenings were still being used.
He shares his expertise on takeaways and discusses UF research looking at a potential link between energy drinks and colorectal cancer risk.
UF Health Cancer Center Rahma Mkuu, Ph.D., discussed the significance of self-collected samples to test for cervical cancer.
UF Health Cancer Center member Helen Moore, Ph.D., is featured in a WUFT article on how she dedicated herself to finding a cure for cancer.
In an interview with OncLive, Amin Sobh, Ph.D., discussed findings on the role of NSD2 in modulating immune surveillance in multiple myeloma.
Christian Jobin, Ph.D., shared his expertise with NPR on how gut bacteria damage may play a role in early-onset colorectal cancer.
The podcast discusses the NRG-GI008 study evaluating what chemotherapy to recommend based on circulating tumor DNA after colon cancer surgery.
In an interview with OncLive, Coy Heldermon, M.D., Ph.D., discusses a trial evaluating epidiferphane given with taxane chemotherapy in breast cancer.
The segment explores the impact of the UF Health Cancer Center's work in the community and cancer screening efforts.